What is Transuite.Org Inc's earnings per share (EPS)?

Transuite.Org Inc (TRSO) reported diluted earnings per share of $-1.52 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Transuite.Org Inc Financials

TRSO

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Transuite.Org Inc (TRSO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TRSO FY2025 2026-06-16

Rapidly reported revenue with near-zero direct costs still fails to fix a cash-hungry, liability-funded balance sheet.

Revenue nearly doubled from $59K in FY2023 to $118K in FY2025. Yet operating cash flow stayed negative at -$69K in FY2025 after -$114K in FY2023, so larger reported volume has not translated into self-funding liquidity.

FY2023 posted $15K of net income while operating cash flow was -$114K, showing that earnings quality has been weaker than the income line alone suggests. Because financing inflows repeatedly bridged operating burn, cash availability appears to depend more on external support than on reported profitability.

The gross margin profile moved from 65.9% in FY2023 to 99.8% in FY2025, an unusual margin shape for a business still consuming cash. Even with assets at $337K, liabilities reached $810K, and the current ratio remained weak, so the balance sheet still looks structurally financed by obligations rather than accumulated capital.

Financial Health Signals

Financial Profile 17/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Transuite.Org Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Liquidity

Transuite.Org Inc's current ratio of 0.40 is below the typical benchmark, resulting in a score of 2/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Piotroski F-Score Weak

2/9

Transuite.Org Inc passes 2 of 9 financial strength tests. No profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$118K

Transuite.Org Inc generated $118K in revenue in fiscal year 2025.

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

$-1.52

Transuite.Org Inc earned $-1.52 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 1588.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$4K

5Y CAGR+82.1%

Transuite.Org Inc held $4K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

61M

Transuite.Org Inc had 61M shares outstanding in fiscal year 2025. This represents an increase of 1413.7% from the prior year.

Margins & Returns

Gross Margin

99.8%

Transuite.Org Inc's gross margin was 99.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs.

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

TRSO Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$118K	$0-100.0%	$59K+440.9%	$11K+187.1%	$4K	N/A
Cost of Revenue	$256	$0-100.0%	$20K+905.0%	$2K-31.4%	$3K	N/A
Gross Profit	$118K	$0-100.0%	$39K+336.7%	$9K+906.7%	$885	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$36K+211.8%	$12K+30.2%	$9K-75.5%	$37K+99.6%	$18K	N/A
Operating Income	N/A	N/A	-$9K+66.9%	-$28K-258.5%	$17K	N/A
Interest Expense	$13K+129.3%	$6K+3.2%	$6K+89.5%	$3K+119.3%	$1K+257.6%	$382
Income Tax	$0	$0	$0	N/A	-$4K-1062.8%	-$339
Net Income	N/A	N/A	$15K+148.4%	-$31K-63.0%	-$19K	N/A
EPS (Diluted)	$-1.52	$-0.09	$0.00	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$122K	N/A	$65K+30.0%	$50K	$0	N/A	$0	$0
Cost of Revenue	$12K	N/A	N/A	N/A	$0	N/A	N/A	N/A
Gross Profit	$110K	N/A	N/A	N/A	$0	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$15K	N/A	$6K+670.9%	$820+696.1%	$103	N/A	$0	$0
Operating Income	N/A	N/A	-$20.9M	N/A	-$483K	N/A	-$190K-346.3%	-$43K
Interest Expense	$47	N/A	$4K+1.4%	$4K+32.0%	$3K	N/A	$0-100.0%	$3K
Income Tax	$0	N/A	$0	$0	$0	N/A	$0	$0
Net Income	N/A	N/A	-$20.9M	N/A	-$486K	N/A	-$190K-320.1%	-$45K
EPS (Diluted)	$-0.05	N/A	$-0.96	$-0.58-866.7%	$-0.06	N/A	$-0.05-400.0%	$-0.01

TRSO Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$337K+371.1%	$72K-62.1%	$189K+355.4%	$41K+608.8%	$6K+3064.3%	$185
Current Assets	$320K+929.8%	$31K-76.8%	$134K+362867.6%	$37-99.4%	$6K+3064.3%	$185
Cash & Equivalents	$4K	$0-100.0%	$11K+29129.7%	$37-99.4%	$6K+3064.3%	$185
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$19K	$0	N/A	N/A	N/A	N/A
Goodwill	N/A	$0	N/A	N/A	N/A	N/A
Total Liabilities	$810K+116.7%	$374K+68.1%	$222K+238.5%	$66K+148.9%	$26K+376.8%	$6K
Current Liabilities	$810K+259.5%	$225K+31.3%	$172K+161.3%	$66K+148.9%	$26K+376.8%	$6K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$485K-56.0%	-$311K-833.6%	-$33K-37.8%	-$24K-17.7%	-$21K-283.8%	-$5K
Retained Earnings	-$37.6M-8097.3%	-$459K-527.0%	-$73K-25.4%	-$58K-310.1%	$28K+208.3%	$9K

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$496K+47.1%	$337K-99.1%	$37.4M+10160.1%	$365K+13.2%	$322K+349.7%	$72K-19.0%	$88K-31.1%	$128K
Current Assets	$455K+41.9%	$320K+6.8%	$300K-9.3%	$331K+16.0%	$285K+815.7%	$31K-28.4%	$43K-45.8%	$80K
Cash & Equivalents	$5K+22.7%	$4K-73.6%	$14K+13930.0%	$100-73.9%	$383	$0-100.0%	$11K0.0%	$11K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$121K+525.8%	$19K+28.7%	$15K-70.0%	$50K	N/A	$0	N/A	N/A
Goodwill	N/A	N/A	$12.5M	N/A	N/A	$0	N/A	N/A
Total Liabilities	$386K-52.3%	$810K-96.5%	$23.2M+7886.3%	$291K-2.7%	$299K-20.1%	$374K+143.3%	$154K-39.6%	$254K
Current Liabilities	$346K-57.3%	$810K+429.2%	$153K+73.0%	$88K-14.3%	$103K-54.2%	$225K+46.7%	$154K0.0%	$154K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$155K+131.9%	-$485K-103.4%	$14.2M+21603.0%	$65K+341.1%	$15K+104.8%	-$311K-377.3%	-$65K+48.2%	-$126K
Retained Earnings	-$40.8M-8.5%	-$37.6M-32.3%	-$28.4M-276.8%	-$7.5M-698.4%	-$945K-106.0%	-$459K-113.9%	-$215K-27.0%	-$169K

TRSO Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$69K+61.6%	-$181K-57.9%	-$114K-536.6%	-$18K-202.7%	$17K	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$3K	$0+100.0%	-$22K+48.2%	-$43K	N/A	N/A
Financing Cash Flow	$51K-72.7%	$186K+26.3%	$147K+169.2%	$55K+136.0%	$23K	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$5K+86.7%	-$41K-163.7%	$64K+414.4%	-$20K+71.6%	-$72K-27.3%	-$57K-1296.8%	-$4K+46.2%	-$8K
Capital Expenditures	$27K	N/A	N/A	N/A	$0	N/A	N/A	N/A
Free Cash Flow	-$32K	N/A	N/A	N/A	-$72K	N/A	N/A	N/A
Investing Cash Flow	-$27K-1494.4%	$2K	N/A	N/A	$0	$0	N/A	N/A
Financing Cash Flow	$33K+28.6%	$26K+150.0%	-$52K-357.1%	$20K-64.2%	$56K+154.2%	$22K+447.2%	$4K-46.2%	$8K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

TRSO Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	99.8%	N/A	65.9%-15.7pp	81.7%+58.4pp	23.3%	N/A
Operating Margin	N/A	N/A	-15.5%+237.4pp	-252.9%-711.0pp	458.0%	N/A
Net Margin	N/A	N/A	25.1%+305.5pp	-280.4%+213.6pp	-494.0%	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	7.8%+81.5pp	-73.7%+246.9pp	-320.7%	N/A
Current Ratio	0.40+0.3	0.14-0.6	0.78+0.8	0.00-0.2	0.22+0.2	0.03
Debt-to-Equity	-1.67-0.5	-1.20+5.5	-6.67-4.0	-2.72-1.4	-1.29-0.3	-1.03
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	90.0%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	-32114.0%	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	-32119.3%	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	-146.9%	N/A	-3275.7%	N/A	N/A	N/A
Return on Assets	N/A	N/A	-55.8%	N/A	-151.0%	N/A	-215.0%-179.8pp	-35.2%
Current Ratio	1.31+0.9	0.40-1.6	1.96-1.8	3.74+1.0	2.76+2.6	0.14-0.1	0.28-0.2	0.52
Debt-to-Equity	2.50+4.2	-1.67-3.3	1.63-2.8	4.44-15.7	20.11+21.3	-1.20+1.2	-2.36-0.3	-2.02
FCF Margin	-26.3%	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$485K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.40), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is Transuite.Org Inc's annual revenue?

Transuite.Org Inc (TRSO) reported $118K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

What is Transuite.Org Inc's gross margin?

Transuite.Org Inc (TRSO) had a gross margin of 99.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Transuite.Org Inc's operating cash flow?

Transuite.Org Inc (TRSO) generated -$69K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Transuite.Org Inc's total assets?

Transuite.Org Inc (TRSO) had $337K in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Transuite.Org Inc have outstanding?

Transuite.Org Inc (TRSO) had 61M shares outstanding as of fiscal year 2025.

What is Transuite.Org Inc's current ratio?

Transuite.Org Inc (TRSO) had a current ratio of 0.40 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Transuite.Org Inc's debt-to-equity ratio?

Transuite.Org Inc (TRSO) had a debt-to-equity ratio of -1.67 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Transuite.Org Inc's cash runway?

Based on fiscal year 2025 data, Transuite.Org Inc (TRSO) had $4K in cash against an annual operating cash burn of $69K. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Transuite.Org Inc's debt-to-equity ratio negative or unusual?

Transuite.Org Inc (TRSO) has negative shareholder equity of -$485K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Transuite.Org Inc's Piotroski F-Score?

Transuite.Org Inc (TRSO) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

How financially healthy is Transuite.Org Inc?

Transuite.Org Inc (TRSO) scores 17 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.